Hiral Labs Limited is pharmaceutical and nutraceutical manufacturer engaged in manufacturing and marketing of finished dosages since year 2000. We are accredited with WHO: GMP, ISO 9001:2015 and ISO 22000:2018 certification. Hiral Labs has two separate manufacturing units, one for pharmaceuticals formulations and another for nutraceutical & dietary supplements. Our third manufacturing unit for Oncology Injections is under construction and will be operational by end of 2023 Insha’Allah.
In domestic market more than 190 brand formulations are offered to prescribing physicians and hospitals. There are more than 80 distributors marketing these products through two marketing divisions namely Hiral Labs Ltd. & Sahet India. Hiral Labs also manufacture around 400 formulations on contractual basis for more than 285 companies in around 4000 brands.Our nutraceutical division Hiral Health is engaged in direct online distribution of dietary and health supplements through major eCommerce platforms like Amazon, Flipkart and Tata 1MG.
Internationally, we are exporting our products to more than 37 countries across 5 continents. Our plant is audited and approved by Philippines MOH, Tanzania FDA, UAE, Yemen amongst several other international Accreditations. We have our overseas associated company RAALI HEALTH INC., Canada and MAPS PHARMA Pvt. Ltd. in Sri Lanka for global marketing & distribution.
Our success is strongly rooted in our belief of Quality Drugs at Affordable Prices, Timely Supplies and Transparent Dealings.